Inuvo Inc (AMEX:INUV) does about 451.93K shares in volume on a normal day but saw 5710377 shares change hands in the recent trading day. The company now has a market cap of 41.63M USD. Its current market price is $0.30, marking an increase of 22.29% compared to the previous close of $0.24. The 52 week high reached by this stock is $0.57 whilst the lowest price level in 52 weeks is $0.19.
Inuvo Inc (INUV) has a 20-day trading average at $0.2312 and the current price is -48.02% off the 52-week high compared with 55.95% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2411 and its 200-day simple moving average is $0.3021. If we look at the stock’s price movements over the week, volatility stands at 13.70%, which decreases to 8.10% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 73.58 to suggest the stock is overbought.
The consensus objective for the share price is $0.95, suggesting that the stock has a potential upside of 68.42% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 28, 2020 when Alliance Global Partners initiated the stock to “Buy” and issued a price target of $2.25. ROTH Capital initiated its price target at $4.50.
The current price level is 28.18%, 22.90%, and -1.92% away from its SMA20, SMA50, and SMA200 respectively, with the INUV price moving below the 50-day SMA on current market day. Inuvo Inc (INUV) stock is up 44.40% over the week and 27.61% over the past month. Its price is -30.28% year-to-date and -9.50% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/30/2024, with the company’s earnings per share (EPS) of -0.01 below consensus estimates by -0.02. The company’s next earnings report forecasts estimating quarterly EPS at -0.0 and -0.04 for whole year. Expected sales for next quarter are $19.13M, which analysts say will come at $82.89M for the current fiscal year and next year at $106.05M. In addition, estimates put the company’s current quarterly revenue at an average of $25.28M.
To reach the target analysts have set, the stock logically needs to grow 68.42 percent from here.
Outstanding shares total 137.98M with insiders holding 14.38% of the shares and institutional holders owning 19.47% of the company’s common stock. The company has a return on investment of -62.87% and return on equity of -53.11%. The beta has a value of 1.14. Price to book ratio is 3.36 and price to sales ratio is 0.53.
